Methylergonovine Side Effects: What to Expect and When to Call Your Doctor

Methylergonovine (Methergine) is a powerful medication used to prevent postpartum hemorrhage after childbirth. Because it acts on uterine smooth muscle and blood vessels, it comes with a meaningful profile of side effects — some expected and manageable, others that require immediate medical attention. Here's what you need to know before and during your course of treatment.

How Methylergonovine Causes Side Effects

Methylergonovine works by stimulating alpha-adrenergic, serotonin (5-HT2A), and dopamine receptors on uterine smooth muscle. This causes strong uterine contractions and some vasoconstriction of blood vessels. Most of its side effects flow directly from these two mechanisms: the uterine contractions cause cramping and related symptoms, while the vasoconstriction can affect blood pressure and the cardiovascular system.

Common Side Effects (Expected and Manageable)

Most patients taking Methylergonovine experience one or more of these side effects:

High blood pressure (hypertension): Due to vasoconstriction. Usually mild and temporary. May manifest as headache, blurred vision, or pounding sensation in ears or neck.

Headache: One of the most frequently reported side effects. Usually relates to blood pressure changes.

Nausea or vomiting: Common, especially with the oral tablet form.

Stomach/abdominal pain: Cramping can occur due to uterine contractions the medication causes.

Dizziness: May occur with blood pressure fluctuations.

Serious Side Effects: When to Seek Immediate Care

Stop taking Methylergonovine and seek immediate medical attention if you experience any of the following:

Sudden, severe headache — may indicate a serious spike in blood pressure or stroke.

Chest pain or pressure — may indicate myocardial ischemia or heart attack due to coronary vasospasm.

Confusion or mental status changes — possible sign of cerebrovascular event.

Trouble breathing — may indicate severe allergic reaction or cardiovascular complication.

Seizures or muscle twitching/jerking — some patients have reported seizures while taking Methylergonovine.

Cold, pale, or numb fingers or toes — sign of peripheral vasospasm, which can lead to ischemia.

Irregular heartbeat or palpitations — may indicate cardiac arrhythmia.

Who Is at Highest Risk for Serious Side Effects?

Certain patients are at elevated risk and require more careful monitoring or should not take Methylergonovine at all:

Patients with hypertension or preeclampsia — Methylergonovine is CONTRAINDICATED

Patients with coronary artery disease, smoking history, diabetes, obesity, or high cholesterol — higher risk of coronary vasospasm

Patients on strong CYP3A4 inhibitors (macrolide antibiotics, HIV medications) — risk of ergot toxicity

Patients with peripheral vascular disease

Breastfeeding and Methylergonovine

Methylergonovine can pass into breast milk. The FDA and most clinical guidelines recommend not breastfeeding within 12 hours after taking Methylergonovine. If you use a breast pump during this 12-hour window, discard that milk — do not feed it to your baby. Discuss the timing of your Methylergonovine doses with your doctor to minimize interference with breastfeeding.

Food and Drug Interactions to Watch

Grapefruit: Avoid grapefruit and grapefruit juice while taking Methylergonovine. Grapefruit inhibits CYP3A4 enzymes, increasing drug levels and risk of side effects.

Macrolide antibiotics (clarithromycin, erythromycin): Contraindicated — risk of severe vasospasm.

Beta-blockers: Use with caution — may enhance vasoconstrictive effects.

Triptans (migraine medications): Contraindicated — additive vasospasm risk.

See our full guide on Methylergonovine drug interactions for a complete list.

How Long Do Side Effects Last?

Methylergonovine oral tablets are prescribed for a maximum of one week postpartum. The medication has a plasma half-life of approximately 3.4 hours (range 1.5–12.7 hours). Most common side effects resolve with the drug course. If side effects are intolerable during the treatment period, contact your doctor — they may reduce the dose frequency or switch you to an alternative.